Inhibrx Announces Participation in Upcoming Investor Conferences

Rhea-AI Summary

Inhibrx, Inc. (NASDAQ: INBX), a clinical-stage biotechnology firm, will present at two upcoming virtual investor conferences: the Jefferies Healthcare Conference on June 2 at 12:30 p.m. PT and the JMP Securities Life Sciences Conference on June 17 at 8:00 a.m. PT. Live webcasts of these presentations can be accessed through the investor section of Inhibrx's website and will remain available for 60 days post-event. The company focuses on developing biologic therapeutic candidates for oncology and orphan diseases, utilizing advanced protein engineering techniques.

SAN DIEGO, May 17, 2021 /PRNewswire/ -- Inhibrx, Inc. (NASDAQ: INBX), a clinical-stage biotechnology company focused on developing a broad pipeline of novel biologic therapeutic candidates, announced today that the Company will be presenting at the following upcoming virtual investor conferences:

• Jefferies Healthcare Conference; Wednesday, June 2nd at 12:30 p.m. Pacific Time
• JMP Securities Life Sciences Conference; Thursday, June 17^th at 8:00 a.m. Pacific Time

The investor conference presentations will be webcast live and may be accessed through a link on the investors section of Inhibrx's website at https://inhibrx.investorroom.com/events-and-presentations. The webcasts will be available for 60 days following the event.

About Inhibrx, Inc.
Inhibrx is a clinical-stage biotechnology company focused on developing a broad pipeline of novel biologic therapeutic candidates in oncology and orphan diseases. Inhibrx utilizes diverse methods of protein engineering to address the specific requirements of complex target and disease biology, including its proprietary sdAb platform. Inhibrx has collaborations with bluebird bio, Bristol-Myers Squibb and Chiesi. For more information, please visit www.inhibrx.com.

Investor and Media Contact:
Amy Conrad
Juniper Point
amy@juniper-point.com
858-366-3243

View original content to download multimedia:http://www.prnewswire.com/news-releases/inhibrx-announces-participation-in-upcoming-investor-conferences-301291482.html

SOURCE Inhibrx, Inc.

FAQ

When will Inhibrx present at the Jefferies Healthcare Conference?

Inhibrx will present at the Jefferies Healthcare Conference on June 2, 2021, at 12:30 p.m. Pacific Time.

What is the date and time for Inhibrx's presentation at the JMP Securities Life Sciences Conference?

Inhibrx's presentation at the JMP Securities Life Sciences Conference is scheduled for June 17, 2021, at 8:00 a.m. Pacific Time.

How can I access Inhibrx's investor conference presentations?

You can access Inhibrx's investor conference presentations via live webcasts on the investor section of their website.

What is Inhibrx's focus area in biotechnology?

Inhibrx focuses on developing novel biologic therapeutic candidates for oncology and orphan diseases.

How long will the webcasts of Inhibrx's presentations be available?

The webcasts of Inhibrx's presentations will be available for 60 days following each event.